Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05316116
Title Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

T-cell large granular lymphocyte leukemia

Therapies

Siltuximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.